Introduction: Since the pandemic of COVID-19 started from December 2019, remarkable
numbers of infections and deaths associated with COVID-19 have been recorded …

Introduction There were discrete outbreaks of SARS-CoV-2 infection in 2021 (Delta wave)
and 2022 (Omicron wave) in Singapore, which affected patients receiving peritoneal dialysis …

In the new pandemic coronavirus disease 2019 (COVID-19) era that started in 2020, early
studies demonstrated that patients with advanced chronic kidney disease such as …

Background Humoral response to the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) vaccines needs to be evaluated in the fragile population of patients on …

We feel deep gratitude to the patients who donated their blood samples and clinical data for
this project. We would like to acknowledge the excellent technical assistance as well as the …

Methods In this cross-sectional, comparative study, the presence or absence of
immunoglobulin G (IgG) anti-S antibody and IgG anti-S antibody titer was compared …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global
healthcare crisis. Kidney transplant (KTx) patients and the patients with chronic kidney …

Abstract Background and Aims Vaccine response is a concern in hemodialysis patients.
Given that hemodialysis patients were not included in clinical trials, we aimed to synthesize …

Abstract The coronavirus disease 2019 (COVID‑19) vaccination is the most effective way to
prevent COVID‑19. However, for chronic kidney disease patients on long‑term dialysis, there …

Background and objectives The immunogenicity of vaccines is known to be attenuated in
patients with end‐stage kidney disease due to uremia. Patients on dialysis were excluded …